GLP-1 medications address several of these pathways simultaneously, and stopping treatment may allow the underlying PCOS-driven metabolic dysfunction to reassert itself
What makes CJC-1295 unique is its long half-life, which allows it to stimulate the release of GH over a prolonged period, rather than in short bursts like natural GHRH
Glial scar is a natural barrier for axonal regeneration, and CTGF plays an important role in the regulation of glial scar [27]
Many patients may avoid drinking fluids due to their queasy stomachs, which can lead to further dehydration
More recently, GLP-1 RA drugs have been approved for weight loss, cardiovascular disease, and chronic kidney disease
Treatment decisions when prescribing SGLT2is and/or GLP-1 RAs in adults with CKD and T2D who have overweight/obesity are strongly influenced by tolerability and safety (88%)